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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2015, KaohsiuAbstract This study aimed to compare the outcomes of standard percutaneous nephrolithot-
omy (PCNL) to PCNL with intraoperative antegrade flexible nephroscopy (IAFN) for treating
stones of staghorn nature. We retrospectively analyzed patients treated using PCNL between
January 2007 and July 2013. A total of 1250 patients were treated using PCNL, and 166 patients
had staghorn stones. All patients had been subjected to a complete blood count, routine
biochemical analyses, coagulation tests, a complete urine analysis, and urine cultures. Pa-
tients with a positive urine culture had been treated with appropriate antibiotics until the ur-
ine culture became negative. After purchasing a flexible renoscope in March 2012, we routinely
used this tool to improve the stone-free (SF) rate. The 105 patients who underwent standard
PCNL prior to March 2012 were classified as Group 1, and the 61 patients who underwent
PCNL þ IAFN after that date were classified as Group 2. The two groups had similar and homo-
geneous demographic data. The fluoroscopy and total operative times were significantly higher
in Group 2 than in Group 1 (p < 0.01). Additionally, the hospitalization time (p < 0.01) and the
mean hematocrit decrease (p < 0.01) were significantly lower in Group 1. In both groups, the
SF rates were higher than 85%, similar to those reported in the literature. Although Group 2 had
a slightly better SF rates, this difference was not statistically significant. For staghorn calculi,eclare no conflicts of interest.
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Standard PCNL vs. PCNL þ IAFN for staghorn stones 569PCNL combined with IAFN yields excellent outcomes. However, similar prospective studies on
larger cohorts should be performed to support our findings.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Staghorn stones occupy a significant volume of the col-
lecting system and are typically defined as stones that are
allocated within at least one calyx and the pelvis. The stone
is called a complete staghorn when it fills the entire col-
lecting system. Staghorn stones have a composition of
magnesium ammonium phosphate and calcium carbonate,
or/and they are infection-associated stones, which have
microorganisms with urease activity [1]. These types of
stones can cause flank pain, progressive renal deteriora-
tion, pyonephrosis, obstruction, or fatal sepsis [2]. For this
reason, complete stone retrieval is crucial.
As residual stones cannot be properly identified during
percutaneous nephrolithotomy (PCNL), the precise deter-
mination of surgical successmay not bepossible [3]. Owing to
the use of radiocontrast agents, the intraoperative diagnosis
of residual fragments using fluoroscopy is difficult. Post-
operative diagnosis of residual fragments increases the need
for auxiliary procedures. The use of multimodal diagnostic
tools is necessary to verify stone clearance.
Although PCNL remains the first choice of treatment [4],
this procedure has a relatively low stone-free (SF) rate
when used for large stone burden. Shock wave lithotripsy
(SWL), flexible ureterorenoscopy, and PCNL may be used in
combinations to increase SF rates.
In this study, we aimed to evaluate the outcomes of
standard PCNL (Group 1) and PCNL with intraoperative
antegrade flexible nephroscopy (IAFN; Group 2) for stag-
horn stones in terms of hemorrhage, number of access,
fluoroscopy and total operative time, hospital stay, and SF
rates.
Methods
After local ethics committee (Diskapi Yildirim Beyazit
Training and Research Hospital, Ankara, Turkey) approval
was granted, we retrospectively evaluated the patients
who were treated using PCNL between January 2007 and
July 2013. A total of 1250 cases had been treated using
PCNL, and 166 of these patients had suffered from staghorn
stones.
Pediatric patients and patient with a history of SWL were
excluded. All patients had been subjected to a complete
blood count, routine biochemical analyses, coagulation
tests, complete urine analysis, and urine culture. Patients
with a positive urine culture had been treated with appro-
priate antibiotics until the urine culture became negative.
After our department purchased a flexible nephroscope
in March 2012, we routinely used this tool to increase the SF
rates. The 105 patients who underwent standard PCNL priorto March 2012 were classified as Group 1, and the 61 pa-
tients who underwent PCNL þ IAFN after that date were
classified as Group 2.
All patients underwent the operation using general
anesthesia. A 6F ureter catheter was placed in the ureter
using a rigid cystoscope in the lithotomy position, and
then patients were repositioned into the prone position.
No nephrostomy catheter had been placed preoperatively
in any patients. After selecting the most appropriate
calyx to reach the stone, an access site was created using
an 18-gauge needle with the aid of retrograde pyelog-
raphy. The nephrostomy tract was formed with plastic
amplatz dilators (Elit Flex, Ankara, Turkey) under fluo-
roscopic imaging. In all patients, 30F working sheaths
were used to perform the operation using a 27F nephro-
scope (Karl Storz, GmbH, Tuttlingen, Germany). A pneu-
matic lithotripter was used for stone disintegration.
Stone fragments were extracted using stone grasping
forceps.
When 4-mm or larger fragments were present, another
appropriate tract was formed for stone removal. The sur-
gery continued until an SF state was achieved using rigid
nephroscopy or until the bleeding reduced vision. When a
hemorrhage occurred, a nephrostomy tube (Elit Flex) was
placed, and the operation had to be ended. These patients
were treated with a second-look PCNL, an antegrade flex-
ible nephroscopy or SWL.
After March 2012, all patients who had fluoroscopic
residual stone that was unreachable with the initial PCNL
access were treated with IAFN (Group 2). At this point,
when a single access was used for PCNL, another access
site was not planned, and IAFN was preferred. Using this
approach, we planned to use Holmium laser to improve
the SF rates. We used a 7.5F flexible nephroscope (Karl
Storz, Flex X2, GmbH) with a Holmium laser (Dornier
MedTech GmbH, Wessling, Germany) to achieve stone
clearance. We preferred 8e12 W of total energy for de-
fragmentation of residual stones. Because of the large
stone burden, we routinely placed an 18F nephrostomy
tube in all cases.
Each group was compared in terms of fluoroscopy,
operative time, and hospital stay, as well as the number of
access sites, the hematocrit decrease, and the SF rates.
The operative and fluoroscopy times were calculated
beginning with the first access site needle puncture and
ending with the placement of the nephrostomy tube. Hos-
pital stay was evaluated from the date of the operation
until the date of discharge. The hematocrit decrease was
calculated using the complete blood count, which was ob-
tained prior to and 1 hour after the operation.
To evaluate the SF status, all patients were evaluated
using kidney, ureter, and bladder (KUB) graphy and
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noncontrast computed tomography during the 3rd post-
operative month. Success was defined as accomplishing
2 mm stones or an SF state. Clinically insignificant resid-
ual fragments were defined as the presence of 2e4-mm
stones.
Statistical data analysis was performed using SPSS
version 15.0 for Windows (SPSS Inc., Chicago, IL, USA). The
significance of differences in the total operative time,
fluoroscopy time, and stone surface area between groups
was assessed using the ManneWhitney U test because of the
nonsymmetric distribution of data. The significance of dif-
ferences in the decrease in hematocrit between groups was
evaluated using the Student t test. The significance of
differences in the SF rate between groups was analyzed
using the Pearson Chi-square test. Differences were
considered significant when p < 0.05.
Results
Both groups had similar and homogeneous demographic
data (Table 1). The fluoroscopy and total operative time
were significantly higher in Group 2 than in Group 1.
Additionally, hospital stay and mean hematocrit
decrease were significantly lower in Group 2. In both
groups, SF rates were higher than 85%, which is consis-
tent with the literature. Although Group 2 had slightly
better SF rates; this difference was not statistically sig-
nificant (Table 2).Table 1 Patient and stone demographics.
P
Age (y) 47
Sex, M/F 55
Stone surface area (mm2) 12
Partial/complete 88
No. of access (single/multi) 83
Laterality (R/L) 53
Access localizations upper calyx/upper & middle calyx 83
IAFN Z intraoperative antegrade flexible nephroscopy; PCNL Z perc
Table 2 Perioperative data, stone-free rate and complications
PCNL (n Z 105
Fluoroscopy time (min) 6.22  3.62
Operative time (min) 95.22  32.64
Hospitalization time (d) 3.96  3.29
Hematocrit decrease (%) 6.80  4.18
No. of access (median) (minemax) 1 (1e3)
Stone-free (1st postoperative day) 85 (80.9)
Stone-free (after 3 mo) 92 (87.6)
Blood transfusion 9 (8.6)
ClavieneDindo Grade 1 33 (31.4)
ClavieneDindo Grade 2 9 (8.6)
ClavieneDindo Grade 3 0
Data are presented as n (%) or mean  SD, unless otherwise indicate
IAFN Z intraoperative antegrade flexible nephroscopy; PCNL Z percDiscussion
The treatment of staghorn stones is challenging. Various
methods have been used, and the optimal treatment
method remains unidentified. PCNL is considered to be an
alternative, when minimally invasive treatments are
preferred.
The main aim of this study was to determine whether
flexible nephroscopy is more appropriate for staghorn kid-
ney stone treatment. To address this matter, Knudsen [5]
proposed the use of aggressive nephroscopy in PCNL for
reducing the need for second-look procedures. Parallel to
that finding, Gu¨cu¨k and colleagues [6] performed a study
with 80 patients who were treated with PNCL using either a
flexible or rigid nephoscope. The authors found that flex-
ible PCNL yielded better outcomes in terms of hematocrit
drop, access sites, and SF rates. However, these authors
also reported that the SF rate improvement depended on
the presence of lower Hounsfield units. Similar to these
findings, our study revealed an insignificant hematocrit
drop and shorter hospital stay in Group 2. Group 2 had
better SF rates than Group 1, but this difference was not
statistically significant. Although our assumption was
achieving shorter operative and fluoroscopy times because
of the lower number of access sites, our results did not
support this hypothesis. This difference can be explained
by the time spent on searching for residual stones with the
fluoroscopy which is considered part of the operative time.
In our series, we did not encounter any majorCNL (n Z 105) PCNL þ IAFN (n Z 61) p
.81  14.42 49.22  14.36 0.544
/50 32/29 0.992
74.33  739.40 1187.13  190.05 0.368
/17 53/8 0.593
/22 55/6 0.065
/52 35/26 0.390
/22 55/6 0.065
utaneous nephrolithotomy.
by ClavieneDindo scores.
) PCNL þ IAFN (n Z 61) p
7.52  2.51 <0.01
113.44  22.84 <0.01
2.39  0.9 0.01
4.31  2.99 <0.01
1 (1e2) 0.03
53 (86.9) 0.135
58 (95) 0.116
2 (3.3) 0.159
12 (19.7) 0.100
2 (3.3) 0.159
0
d.
utaneous nephrolithotomy; SD Z standard deviation.
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among groups, in Group 1, 40% of patients suffered from
minor complications whereas 23% of patients had compli-
cations in Group 2. We believe using flexible instruments
and avoiding lateral forcing may account for this differ-
ence. Also, the addition of IAFN to PCNL reduced hemato-
crit loss and hospital stay; this difference may account for
the reduced injury of the renal parenchyma that occurs
with the use of fewer access sites.
Wong and Leveillee [7] published their experience of 49
patients managed using second-look flexible renoscope
after PCNL. They reported a hospital stay ofw3e4 days [7].
However, we propose a shorter hospital stay that may be
achieved using synchronous IAFN after PCNL (Table 2).
PCNL can be applied using multiple accesses to the
kidney. Desai et al [8] reported their findings on PCNL
treatment with more than one access site and named this
procedure “multiperc.” They compared 500 patients who
were treated using multiperc against 225 single-tract
treatments and revealed significantly higher blood trans-
fusion rate, longer hospital stay, and increased urine
leakage. Stone clearance rates of the procedures were
similar, despite the higher complication rates [8]. In a
similar article published by Aron et al [9], a mean of 3.28
access sites were used in renal units for staghorn stone
treatment. Using this approach, the authors achieved an
85% SF rate. In addition, they performed adjuvant SWL, and
the SF rate improved to 94% [9]. By contrast, in our study,
we had to perform more than one access site in 31 cases in
Group 1, whereas five cases had to be managed with more
than one access in Group 2 (p Z 0.03). Williams and Lev-
eillee [10] proposed that flexible nephroscopy with a single
percutaneous access site is the best method of treating
staghorn calculi. They reported their case, wherein they
used an upper calyx access, and proposed an upper pole
access with flexible nephroscopy for all cases with staghorn
calculi [10]. In another article by the same authors con-
cerning the same issue, again, a 90% success rate in pa-
tients with staghorn stones who were treated using PCNL
with a single access site and flexible nephroscopy was re-
ported [11]. Undre et al [12] proposed a combination of
anterograde and retrograde instruments for PCNL to reduce
the number of tracts. Our study reveals similar outcomes,
suggesting that flexible nephroscopy with a single access
site can yield comparable results.
El-Nahas et al [13] treated 241 patients with staghorn
stones with PCNL and reported an SF rate of 56%. When they
added adjuvant SWL, the SF rate stayed as low as 27% [13].
In another study performed by the same researchers, the
reported SF rate was 56.6% after PCNL treatment in patients
with staghorn stones. With additional interventions, after 3
months, the SF rate increased to 72.7% [14]. Wong and
Leveillee [7] reported 45 renal unit experiences with addi-
tional IAFN following PCNL. In this article, a nephrosto-
graphic control on the 3rd postoperative day was preformed,
and if required a second-look PCNL using a flexible nephro-
scope was added to the treatment regime. In that series, the
SF rate was 95% [7]. Aggressive stone clearance and the use
of IAFN reduce the requirement for routine second-look
procedures [15]. In our study, we achieved an SF rate of
87.6% in the rigid nephroscopy group. A 95% SF rate was
achieved in Group 2 after treatment with IAFN.Even though this is the first study to evaluate the out-
comes of PCNL only versus PCNL combined with flexible
nephroscopy for staghorn stones, this study has several
limitations: its retrospective nature and the relatively small
number of patients involved. Moreover, stone density was
not assessed, and no long-term follow-up was conducted to
demonstrate the renal functional advantages of each
procedure.
In conclusion, for staghorn calculi, PCNL combined with
IAFN yields excellent outcomes and reduced morbidity.
However, similar prospective studies on larger cohorts
should be performed to support our findings.
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